Search

Search Results

• Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies

  Claudia Paganini, Edoardo Mortato, Lorenzo Tofani, Alfredo Belcastro, Marina Talamonti, Cosimo Di Raimondo, Luca Bianchi, Marco Galluzzo

  04-03-2025

  https://doi.org/10.4081/dr.2025.10193

  1397

  PDF: 621

  HTML: 47

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2867

  PDF: 1015

  HTML: 40

• Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

  Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi

  16-10-2025

  https://doi.org/10.4081/dr.2025.10588

  462

  PDF: 234

  HTML: 4

• Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient Use of upadacitinib in pediatric comorbidities

  Edoardo Mortato, Ludovico Maria Rao, Marina Aloi, Arnaldo Cioni, Enrico Matteini, Angela Fico, Sara Lambiase, Ruslana Gaeta Shumak, Luca Bianchi, Elena Campione, Laura Diluvio

  09-01-2026

  https://doi.org/10.4081/dr.2026.10165

  838

  PDF: 542
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9678

  2530

  PDF: 1454

  HTML: 128

• Refractory pityriasis rubra pilaris treated with abrocitinib

  Filip Rob

  09-01-2025

  https://doi.org/10.4081/dr.2025.10105

  521

  PDF: 331

  HTML: 27

• Successful use of upadacitinib for the improvement of vitiligo-like and perifollicular dyspigmentation (salt-and-pepper skin) in systemic sclerosis

  Giovanni Paolino, Matteo Riccardo Di Nicola, Santo Raffaele Mercuri, Valentina Canti

  12-02-2026

  https://doi.org/10.4081/dr.2026.10652

  500

  PDF: 364

• Upadacitinib for the management of refractory hidradenitis suppurativa, psoriasis, and pyoderma gangrenosum

  Giorgia Sbarra, Edoardo Mortato, Francesco Loconsole

  03-02-2026

  https://doi.org/10.4081/dr.2026.10314

  640

  PDF: 433

• Scabies mimicking relapsing atopic dermatitis

  Flavia Pigliacelli, Elva Abril, Norma Cameli, Paolo Iacovelli, Maria Mariano

  09-08-2024

  https://doi.org/10.4081/dr.2024.10070

  1119

  PDF: 718

  HTML: 113

• Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

  Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris

  03-02-2026

  https://doi.org/10.4081/dr.2026.10644

  785

  PDF: 523

• Keratosis lichenoides chronica: a case report with dermatoscopic and ultrasonographic analysis

  Katarzyna Korecka, Monika Bowszyc-Dmochowska, Nina Łabędź, Ryszard Żaba, Aleksandra Dańczak-Pazdrowska, Adriana Polańska

  11-06-2025

  https://doi.org/10.4081/dr.2025.10093

  526

  PDF: 397

  HTML: 53

• Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

  Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili

  13-03-2025

  https://doi.org/10.4081/dr.2025.10021

  545

  PDF: 370

  HTML: 16

• 30 | ATOPIC DERMATITIS AND ULCERATIVE COLITIS: A CASE REPORT ON THE MANAGEMENT OF OVERLAPPING COMORBIDITIES S. Senatore¹, C. Cardinali¹, A. Pieraccini², F. Taviti¹ | ¹SOC Dermatologia Pistoia-Prato, USL Toscana Centro, Italy; ²SOC Gastroenterologia ed Endoscopia, USL Toscana Centro, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11092

  126

  PDF: 42
• 

  Acne exacerbation after tofacitinib treatment for alopecia areata

  Sawsan Alharthi, Mohammed G. Turkmani, Mohammed I. AlJasser

  01-01-2022

  https://doi.org/10.4081/dr.2022.9396

  2682

  PDF: 893

  HTML: 44